News & Analysis as of

Alibaba Pharmaceutical Industry

Robins Kaplan LLP

Financial Daily Dose 4.12.2021 | Top Story: Chinese Regulators Hit Alibaba With $2.8B Antitrust Fine

Robins Kaplan LLP on

Chinese antitrust officials hit Alibaba with a “record” $2.8 billion fine over the weekend—the “biggest move yet in the government’s campaign to tighten its supervision of Big Tech.” ...more

Robins Kaplan LLP

Financial Daily Dose 3.16.2021 | Top Story: Purdue Pharma Unveils Post-Bankruptcy Plans, Including $4.7B Payment by Sacklers

Robins Kaplan LLP on

Purdue Pharma has outlined its own plan to remove Sackler family control and restructure the pharmaceutical giant on the other side of bankruptcy—a 300-page effort that amounts to the company’s “formal bid to end thousands of...more

Robins Kaplan LLP

Financial Daily Dose 5.18.2020 | Top Story: Uber Eliminates 3,700 Jobs

Robins Kaplan LLP on

Uber Technologies Inc. will eliminate 3,700 jobs. This equates to the company shedding a quarter of its workforce. Rumors are also circulating that Uber “is in talks to buy rival Grubhub Inc.”....more

Robins Kaplan LLP

Financial Daily Dose 5.28.2019 | Top Story: Fiat Chrysler and Renault in Talks to Merge

Robins Kaplan LLP on

Fiat Chrysler and struggling post-Ghosn French automaker Renault are in talks to complete a merger of equals that could “reshape the global automobile industry.” If a deal is reached the combined company would be the third...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

As expected based on buzz from late last week, longtime CBS chief Les Moonves is out at the network he’s led for more than 20 years.  While his exit has been in the works for some time, a report out yesterday detailing new...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Most insiders are chalking up last week’s CVS/Aetna news to a recent Amazon push into the pharma world. The Journal breaks down exactly what that means—both for the industry and for Amazon, which faces a series of challenges...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Mylan will pay $465 million to federal authorities to resolve claims that it overcharged the Medicaid program by millions for its EpiPen products. Though large, the figure represents about a third of the estimated...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Klaus Kleinfeld is out as CEO of Alcoa-subsidiary Arconic. Kleinfeld’s two-year tenure was marked by problems, and Kleinfeld did himself no favor with an un-Board-authorized letter that he sent to activist-investor Elliott...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Some good news for the UK after a brutal few days for the pound? It appears that the pound’s precipitous fall has acted as a sort of “giant shock absorber” against Brexit—a release valve of sorts that has meant decreased...more

Robins Kaplan LLP

Your daily dose of financial news - The Brief - 9.2.16

Robins Kaplan LLP on

Turns out that the Anbang Insurance Group—the powerful Chinese insurer that’s made plenty of Brief appearances for its massive bids on US hotels, among others—really does live up to its air of mystery, with many of its...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide